Issue 132 • July 2023

AI for patients: Hype or Hope

While recent advancements see companies highlighting AI’s ability to empower patients, there is reluctance to fully embrace it

Briefing

Intercept winds down NASH programme after FDA pulls plug on Ocaliva

Interview

How Big Pharma implements analytics in continuous manufacturing

In Depth

Inflation reduction act boosts biologic VC financing over small molecules

In Data

Leading innovators in aircraft air conditioning

Thematic Take

Metaverse in Pharma

Go to article: Home | AI for patients: Hype or HopeGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article:  Sensified.ioGo to article: In DepthGo to article: AI for patients: Hype or HopeGo to article: Readmission on the Horizon: How EU funding can boost British biotechGo to article: NASH drugs race to cross the finish lineGo to article: Can vouchers incentivise antimicrobial drug discovery in Europe?Go to article: Q&A: How Big Pharma implements analytics in continuous manufacturingGo to article: Inflation reduction act boosts biologic VC financing over small molecules Go to article: B Medical SystemsGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: ForewordGo to article: An introduction to the metaverseGo to article: A history of the metaverseGo to article: The impact of the metaverse on the healthcare sector Go to article: Case studies: the metaverse in the healthcare industry Go to article: Latest news: metaverse in pharmaGo to article: Apple makes a play to change the health Metaverse arenaGo to article: Why is the healthcare industry hesitant to join the metaverseGo to article: Deal activity related to the metaverse in the pharmaceutical industry since 2018Go to article: Metaverse hiring trends in the global pharmaceutical industry since 2020Go to article: Metaverse patent applications in the global pharmaceutical industry since 2020Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: Thermo Fisher ScientificGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue